Your Messages Inbox
Your Article Summary
See Latest ArticlesInitial Therapy with JANUMET (sitagliptin/metformin) Provided Significantly Greater Blood Sugar Lowering Compared to Metformin Alone in Patients with Type 2 Diabetes
Merck & Co., 06/09/09
New data presented at the American Diabetes Association 69th Annual Scientific Sessions showed that initial treatment with JANUMET provided greater blood sugar improvements in drug-naive patients with type 2 diabetes, compared with metformin alone. In separate post-hoc analyses, data pooled from studies of 104 weeks in duration showed JANUVIA, when taken alone or in combination with metformin, provided significant blood sugar lowering, which was sustained over two years.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Conference Call to Discuss Clinical Data Reported at Recent Medical Meetings
ImmunoGen, Inc., 12/04/09
Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematology Annual Meeting
Allos Therapeutics, 12/04/09
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to be Presented at the 32nd Annual San Antonio Breast Cancer Symposium
Cytokinetics, 12/04/09
Article Search
Sponsor